Patients with recent myocardial infarction (MI) and low ejection fraction (EF) are at highest risks of sudden cardiac death. The benefits of early cardioverter-defibrillators in this population remains unclear. We… Click to show full abstract
Patients with recent myocardial infarction (MI) and low ejection fraction (EF) are at highest risks of sudden cardiac death. The benefits of early cardioverter-defibrillators in this population remains unclear. We performed a meta-analysis of randomized controlled trials (RCTs) that evaluated the
               
Click one of the above tabs to view related content.